Werbung
Werbung

CYCN

CYCN logo

Cyclerion Therapeutics, Inc. Common Stock

1.70
USD
Gesponsert
-0.23
-12.18%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

1.82

+0.13
+7.67%

CYCN Ergebnisberichte

Positives Überraschungsverhältnis

CYCN übertreffen die 6 der letzten 13Schätzungen.

46%

Nächster Bericht

Datum des nächsten Berichts
02. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
--
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
--

Cyclerion Therapeutics, Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, CYCN reported earnings of -0.30 USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 880.00 tausend, compared to an expected --, with a --% difference. The market reacted with a +1.41% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Cyclerion Therapeutics, Inc. Common Stock reported EPS of -$0.30, missing estimates by --, and revenue of $880.00K, -- -- expectations.
The stock price moved up 1.41%, changed from $1.42 before the earnings release to $1.44 the day after.
The next earning report is scheduled for 02. März 2026.
Based on -- analysts, Cyclerion Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung